SCI Abstract

search
+
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
Chanson P, Maiter D. The epidemiology, diagnosis and treatment of prolactinomas: the old and the new...
Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)
Sukul N, Karaboyas A, Csomor PA, et al. Self-reported pruritus and clinical, dialysis-related, and p...
The future of drugs distribution in the National Health System
Medaglia, M., Buzzetti, G., Cossolo, M., Deambrosis, P., & Scroccaro, G. (2024). The future of drugs distribution i...
Clinical and economic burden of peristomal skin complications: Activity Based Costing analysis
Robertson I, Leung E, Hughes D, et al. Prospective analysis of stoma-related complications. Colorect...
Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345-360. https://doi.o...
Time to market access in Italy: duration of the P&R process for rare disease drugs
Kwon HY, Kim H, Godman B. Availability and Affordability of Drugs With a Conditional Approval by the...
Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2−, node-positive, high-risk early breast cancer in Italy
Cancer.Net. Breast cancer: statistics. https://www.cancer.net/cancer-types/breast-cancer/statistics....
Unmet need: definitions, literature evidence and implications for HTA
Caprari F, Alfano A, Buzzetti G, et al. [Unmet clinical need and new therapeutic options.]. Recenti ...
Good practices for the development of budget impact models at regional level
Linee guida per la compilazione del dossier a supporto della domanda di rimborsabilità e prezzo di u...
COVID-19 impact on the decision process of the Italian Medicine Agency: a quantitative assessment
Guidelines for pricing and reimbursement of medicines (determina DG/1372/2020) [Internet]. Agenzia I...
Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
Preckler V, Espín J. The Role of Indication-Based Pricing in Future Pricing and Reimbursement Polici...
Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy
AIOM: Linee guida del Carcinoma della Prostata. 2021. Online https://snlg.iss.it/wp-content/uploads/...
Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections
Cassini A, Högberg LD, Plachouras D, et al; Burden of AMR Collaborative Group. Attributable deaths a...
The role of patient-reported outcomes in reimbursement decisions and drug innovation in Italy
Brogan AP, DeMuro C, Barrett AM, D’Alessio D, Bal V, Hogue SL. Payer Perspectives on Patient-Reporte...
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis
Consensus development conference. Consensus development conference: diagnosis, prophylaxis, and trea...
Drugs territorialization in the era of PNRR: perspectives, opportunities and considerations from a panel of experts
1.Marata AM, Marrocco W, Arcangeli E, Battistini M, Buzzetti G, Candido R, Casadei G, Cattel F, Cavaliere A, Consoli A, Co...
Disability weights for castration-resistant prostate cancer: an empirical investigation
World Bank. World Development Report 1993: Investing in Health. Online https://openknowledge.worldba...
Cost per responder for methotrexate versus other therapies in patients with moderate-to-severe plaque psoriasis in Italy
Damiani G, Bragazzi NL, Karimkhani Aksut C, et al. The Global, Regional, and National Burden of Psor...
Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain
Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90(...
Treatment management of patients with systemic lupus erythematosus: a delphi consensus analysis
Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. 2022 Jul 8. In: StatPearls [...
Economic evaluation of treosulfan in patients undergoing allogeneic haematopoietic stem cell transplantation
Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size do...
Value generated by the multiplier effect of investments by the pharmaceutical industry in Italy: proposals to promote competitiveness and attractiveness
Indicatori Farmaceutici. Farmindustria 2021,2022. Online. https://www.farmindustria.it/documenticate...
Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
1.Jommi C, Apolone G, Scroccaro G, Acciai V, Addis A, Ardizzoni A, Bernardini R, Bortolami A, Brigido A, Buzzetti G, Canon...
Budget Impact analysis of a new system of care in Parkinson’s disease patients
European Parkinson’s Disease Association. What is Parkinson’s disease? Online https://www.epda.eu.co...
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOB...
The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study
Authors Arianna Bertolani CERGAS (Centre for Research on H...
Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines
1.Martínez-Sesmero JM, Smith B, Madurga J. Analysis of the evolution of the price of oncology drugs after the loss of thei...
Introduction of the telemonitoring device Turbo+ in the management of patients suffering from asthma in Italy: a budget impact analysis
Global Asthma Network. The Global Asthma Report 2018. Online: http://globalasthmanetwork.org/Global%...
Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP)
Regione autonoma Friuli Venezia Giulia. Linee Guida Regionali per la Gestione delle Polmoniti Batter...
Distribution methods of ostomy and incontinence aids in the Italian healthcare setting: an evaluation questionnaire and social burden of direct distribution
Decreto del Presidente del Consiglio Dei Ministri – 12 gennaio 2017 – Definizione e aggiornamento de...
Load More
format_indent_increase